Processus Wealth & Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.54M Sell
10,770
-206
-2% -$82.1K 2.64% 14
2026
Q2
$3.97M Buy
10,976
+254
+2% +$86.9K 2.35% 16
2026
Q1
$3.77M Sell
10,722
-33
-0.3% -$11.8K 2.56% 19
2025
Q4
$3.52M Buy
10,755
+163
+2% +$51.7K 2.32% 21
2025
Q3
$2.99M Buy
10,592
+246
+2% +$71.3K 2.14% 21
2025
Q2
$2.89M Buy
10,346
+1,934
+23% +$548K 2.28% 20
2025
Q1
$2.62M Buy
8,412
+185
+2% +$54.6K 2.23% 19
2024
Q4
$2.14M Sell
8,227
-696
-8% -$206K 1.71% 23
2024
Q3
$2.88M Sell
8,923
-959
-10% -$314K 2.37% 19
2024
Q2
$3.09M Buy
9,882
+123
+1% +$36.1K 2.56% 16
2024
Q1
$2.77M Buy
9,759
+1,293
+15% +$378K 2.46% 18
2023
Q4
$2.44M Buy
+8,466
New +$2.31M 2.44% 19

Other funds holding AMGN

Processus Wealth & Capital Management's AMGN Position: Q3 2026 in Review

Processus Wealth & Capital Management reduced its Amgen (AMGN) stake by 1.9% in Q3 2026, selling an estimated $82.1K and leaving 10,770 shares worth $4.54M. The position accounts for 2.64% of the portfolio, ranked #14.

Processus Wealth & Capital Management first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 1,149 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Processus Wealth & Capital Management held 10,770 shares of Amgen worth $4.54M as of Q3 2026.
  • Processus Wealth & Capital Management sold 206 Amgen shares in Q3 2026, an estimated $82.1K.
  • Amgen made up 2.64% of Processus Wealth & Capital Management's portfolio in Q3 2026, its #14 holding.
  • Processus Wealth & Capital Management first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • 1,149 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Processus Wealth & Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.